Literature DB >> 12477873

Responses of herpes simplex virus type 1-infected cells to the presence of extracellular antibodies: gE-dependent glycoprotein capping and enhancement in cell-to-cell spread.

Syed Monem Rizvi1, Malini Raghavan.   

Abstract

Binding of anti-herpes simplex virus (HSV) immunoglobulin G (IgG) to HSV type 1 (HSV-1)-infected HEL and HEp-2 cells causes changes in surface viral glycoprotein distribution, resulting in a capping of all viral glycoproteins towards one pole of the cell. This occurs in a gE-dependent manner. In HEL cells, low concentrations of anti-HSV IgG also enhance cell-to-cell spread of wild-type HSV-1 but not of gE deletion mutant HSV-1. These observations raised the possibility that gE-dependent mechanisms exist that allow some HSV-1-infected cells to respond to the presence of extracellular antibodies by enhancing the antibody-resistant mode of virus transmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477873      PMCID: PMC140612          DOI: 10.1128/jvi.77.1.701-708.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells.

Authors:  H W Favoreel; H J Nauwynck; P Van Oostveldt; T C Mettenleiter; M B Pensaert
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Structure-function analysis of the gE-gI complex of feline herpesvirus: mapping of gI domains required for gE-gI interaction, intracellular transport, and cell-to-cell spread.

Authors:  J D Mijnes; B C Lutters; A C Vlot; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication.

Authors:  F A Zuckermann; T C Mettenleiter; C Schreurs; N Sugg; T Ben-Porat
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Glycoprotein E of bovine herpesvirus type 1 is involved in virus transmission by direct cell-to-cell spread.

Authors:  X Rebordosa; J Piñol; J A Pérez-Pons; J Lloberas; J Naval; X Serra-Hartmann; E Espuña; E Querol
Journal:  Virus Res       Date:  1996-11       Impact factor: 3.303

6.  Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins.

Authors:  J C Whitbeck; A C Knapp; L W Enquist; W C Lawrence; L J Bello
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.

Authors:  T Matsumura; T Kondo; S Sugita; A M Damiani; D J O'Callaghan; H Imagawa
Journal:  Virology       Date:  1998-03-01       Impact factor: 3.616

8.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ.

Authors:  P Balan; N Davis-Poynter; S Bell; H Atkinson; H Browne; T Minson
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

10.  Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.

Authors:  D C Johnson; M C Frame; M W Ligas; A M Cross; N D Stow
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  7 in total

1.  Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites.

Authors:  Rebecca M Mingo; Jun Han; William W Newcomb; Jay C Brown
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Pseudorabies virus triggers glycoprotein gE-mediated ERK1/2 activation and ERK1/2-dependent migratory behavior in T cells.

Authors:  Maria Setas Pontes; Bert Devriendt; Herman W Favoreel
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

3.  Copatching and lipid raft association of different viral glycoproteins expressed on the surfaces of pseudorabies virus-infected cells.

Authors:  Herman W Favoreel; Thomas C Mettenleiter; Hans J Nauwynck
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Prohibitin-1 Contributes to Cell-to-Cell Transmission of Herpes Simplex Virus 1 via the MAPK/ERK Signaling Pathway.

Authors:  Mizuki Watanabe; Jun Arii; Kosuke Takeshima; Ayano Fukui; Masayuki Shimojima; Hiroko Kozuka-Hata; Masaaki Oyama; Takeharu Minamitani; Teruhito Yasui; Yuji Kubota; Mutsuhiro Takekawa; Isao Kosugi; Yuhei Maruzuru; Naoto Koyanagi; Akihisa Kato; Yasuko Mori; Yasushi Kawaguchi
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.

Authors:  Elizabeth R Sprague; Chu Wang; David Baker; Pamela J Bjorkman
Journal:  PLoS Biol       Date:  2006-05-02       Impact factor: 8.029

6.  The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface.

Authors:  Blaise Ndjamen; Alexander H Farley; Terri Lee; Scott E Fraser; Pamela J Bjorkman
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

Review 7.  Alphaherpesvirus glycoprotein E: A review of its interactions with other proteins of the virus and its application in vaccinology.

Authors:  Yaru Ning; Yalin Huang; Mingshu Wang; Anchun Cheng; Qiao Yang; Ying Wu; Bin Tian; Xumin Ou; Juan Huang; Sai Mao; Di Sun; Xinxin Zhao; Shaqiu Zhang; Qun Gao; Shun Chen; Mafeng Liu; Dekang Zhu; Renyong Jia
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.